Don Dempsey reportedly in frame to serve as Office of Management and Budget’s leading health offical, a role that would hand him sweeping powers to rein in Kennedy’s ambitions ...

HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, financial disclosures show. The documents, which STAT obtained ...

Inside details from the autopsy of Robert F. Kennedy could unveil the chilling truth behind the U.S. senator‘s violent death.

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

Experts call the health implications “dire” with some fearing Kennedy could set off a fresh round in the school culture wars ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

In his inaugural address, President Donald Trump promised to reform the public health system and reverse actions taken ...

Jon Hochschartner Anyone who cares about animals should oppose Robert F. Kennedy Jr., President-Elect Donald Trump’s nominee for secretary of Health and Human Services. Available evidence suggests he ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Restored to power, President Trump claimed that God put him there and asserted the right to single-handedly redraw the world ...